Depression is one of the most common and disabling mental health conditions in the United States. For some people, symptoms can substantially interfere with daily activities, relationships, work, and quality of life (National Institute of Mental Health, n.d.). At Revitalize Ketamine Clinic in Sedona, AZ, we see this reality firsthand: people who have tried multiple medications over years and still find themselves struggling to function, feel hope, or engage with daily life.
What brings many people to our clinic is the growing research behind IV ketamine therapy, a treatment that works through a different mechanism than traditional antidepressants. In a randomized controlled trial of adults with treatment-resistant major depression, a single ketamine infusion produced greater improvement in depression severity at 24 hours than an active placebo, though individual response and durability vary (Murrough et al., 2013). For more context on the medication’s clinical background, read where ketamine comes from and how it has been used medically.
Set against the sweeping red rock landscapes of Sedona’s canyon country, our clinic offers a healing environment that many patients find calmer and more restorative than a conventional medical setting.
Understanding Treatment-Resistant Depression
Treatment-resistant depression does not have one universally accepted definition. However, the most common research definition involves inadequate response to at least two previous antidepressant trials delivered at an adequate dose and duration (Gaynes et al., 2020). This is more common than many people realize and can leave patients without adequate relief through conventional care alone.
Standard antidepressants primarily affect monoamine neurotransmitter systems such as serotonin, norepinephrine, and dopamine. IV ketamine works primarily through the glutamate system as an NMDA receptor antagonist, which is a distinct biological pathway (Sanacora et al., 2017).
Preclinical research suggests that NMDA receptor antagonism may affect synaptic signaling and plasticity in ways relevant to antidepressant effects. These findings are important to ongoing research, but they do not establish that synaptogenesis is the direct cause of improvement for an individual patient (Li et al., 2010).
Results vary by individual, and ketamine is not appropriate for every person with depression. We conduct a thorough intake evaluation before recommending any treatment, and we encourage you to discuss all options openly with your provider.
How IV Ketamine Works at Our Sedona Clinic
At Revitalize Ketamine Clinic in Sedona, IV ketamine infusions for depression are administered in a carefully monitored clinical environment. Revitalize states that patients typically receive a series of six infusions over two to three weeks, with each infusion lasting approximately 45 minutes. Doses and infusion times are tailored to the individual’s condition, response, and overall health.
The doses used for psychiatric applications are lower than anesthetic doses. Ketamine for depression is an off-label use of the medication, meaning ketamine’s FDA-approved uses are anesthetic indications rather than psychiatric treatment (U.S. Food and Drug Administration, 2022; Sanacora et al., 2017). We discuss this distinction openly with every patient so expectations are grounded in realistic, evidence-based information.
Some patients notice changes in mood quickly, while others do not experience the same timeline or degree of response. Ketamine should not be viewed as a guaranteed or standalone solution. It is one possible component of a broader care plan.
One barrier that prevents many patients from pursuing ketamine treatment is cost. At Revitalize, IV ketamine is self-pay. Our Arizona access-and-coverage guide explains the current distinctions between IV ketamine, insurance-covered SPRAVATO® treatment, and other options. We discuss pricing during consultation so patients can make informed decisions.
The Sedona Healing Environment
There is a reason Sedona has drawn people seeking wellness and restoration for generations. The iconic red sandstone formations, clarity of the high desert sky, and tranquility of Oak Creek Canyon create an atmosphere that many people find conducive to reflection and healing.
While our clinical practice is grounded in evidence-based care, we also recognize that a person’s environment can shape how they experience treatment. Patients at our Sedona location often describe arriving with a sense of calm before they walk through the door.
We encourage patients to use the days around infusions intentionally. A quiet walk among the red rocks, time in nature, and journaling may be meaningful ways to reflect around treatment when they align with a patient’s care plan. Revitalize also offers integration talk therapy as part of its broader approach to support.
Who May Be a Candidate for IV Ketamine
Candidates for IV ketamine therapy at our Sedona clinic may include people with depression who have not found adequate relief after prior treatment. Some patients may also experience co-occurring anxiety symptoms, which should be considered as part of a full psychiatric evaluation.
Candidacy is determined through a comprehensive clinical evaluation. Our guide on how to find a ketamine clinic and evaluate your options outlines questions patients can ask when considering care.
Patients should discuss their full medical history, psychiatric history, medications, and any substance-use concerns with their provider before beginning treatment. Some health conditions or psychiatric histories may require additional assessment or make ketamine inappropriate.
Ongoing Care and Maintenance
Following an induction series, some patients may return for maintenance infusions based on their clinical response and provider recommendation. Maintenance schedules vary considerably. Revitalize notes that maintenance infusions may be scheduled monthly, quarterly, or as needed depending on the individual’s situation.
We see ketamine as one component of a broader treatment approach rather than a standalone solution. Continuing appropriate psychotherapy, medication management, and existing therapeutic relationships can remain important parts of care.
Frequently Asked Questions
What is IV ketamine therapy for depression, and how is it different from antidepressants?
IV ketamine works primarily through the glutamate system and NMDA receptor antagonism, rather than the serotonin, norepinephrine, or dopamine systems targeted by many conventional antidepressants. Controlled research has found rapid antidepressant effects for some people, but individual results and duration of benefit vary. Ketamine for psychiatric purposes is an off-label use.
How many IV ketamine infusions will I need?
Revitalize states that a typical induction series consists of six infusions over two to three weeks. The exact schedule is individualized based on your medical history, treatment response, and provider recommendation.
Is IV ketamine covered by insurance?
IV ketamine at Revitalize is self-pay. Our ketamine access-and-coverage guide explains current payment and coverage distinctions. Please contact our Sedona office at 928-325-2323 to discuss current pricing.
What does a ketamine infusion feel like?
At the doses used for depression treatment, patients may experience altered perceptions, a dreamlike or dissociative state, and changes in their sense of time. These effects are temporary. Our clinical staff is present throughout treatment to monitor comfort and safety. Visit our ketamine FAQs for additional information.
Can I combine IV ketamine with my existing antidepressants or therapy?
Many patients continue psychiatric medications and psychotherapy while pursuing ketamine treatment, but decisions about medication and therapy should be individualized. Your provider will review your current medications and treatment history during intake. Do not start, stop, or change medication without speaking with your prescribing clinician.
Key Takeaways
- IV ketamine works through the glutamate system, a distinct mechanism from conventional antidepressants.
- Ketamine for depression is an off-label treatment supported by a growing body of research, but outcomes vary by individual.
- Revitalize states that a typical induction series consists of six IV infusions over two to three weeks, with continuous clinical monitoring.
- Cost and uncertainty about the infusion experience are common barriers. We address both through transparent discussions and thorough pre-treatment consultations.
- Sedona’s natural environment supports our holistic treatment philosophy, while clinical care remains individualized and evidence-informed.
At Revitalize Ketamine Clinic in Sedona, we believe that patients who have struggled with treatment-resistant depression deserve honest, evidence-based options delivered with compassion and clinical rigor. To explore whether IV ketamine therapy may be appropriate for you, schedule a consultation with our team. You can also reach our Sedona office directly at 928-325-2323, our Flagstaff location at 928-589-0567, or our Prescott Valley location at 928-493-8222.
References
Gaynes, B. N., Lux, L., Gartlehner, G., Asher, G., Forman-Hoffman, V., Green, J., Boland, E., Weber, R. P., Randolph, C., Bann, C., Coker-Schwimmer, E., Viswanathan, M., & Lohr, K. N. (2020). Defining treatment-resistant depression. Depression and Anxiety, 37(2), 134–145. https://doi.org/10.1002/da.22968
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science, 329(5994), 959–964. https://doi.org/10.1126/science.1190287
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., Charney, D. S., & Mathew, S. J. (2013). Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site randomized controlled trial. American Journal of Psychiatry, 170(10), 1134–1142. https://doi.org/10.1176/appi.ajp.2013.13030392
National Institute of Mental Health. (n.d.). Major depression. https://www.nimh.nih.gov/health/statistics/major-depression
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., Summergrad, P., Nemeroff, C. B., & American Psychiatric Association Council of Research Task Force on Novel Biomarkers and Treatments. (2017). A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry, 74(4), 399–405. https://doi.org/10.1001/jamapsychiatry.2017.0080
Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy, TMS, SPRAVATO®, and medication management should only be pursued under the supervision of a licensed provider familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide & Crisis Lifeline or go to your nearest emergency room.